U.S. Household Products Stock News

DoorDash (DASH) is back in focus after its latest earnings triggered sharp moves in the stock, with strong year-over-year growth, an earnings miss, and fresh concerns around tariffs and AI related disruption all colliding. See our latest analysis for DoorDash. Those sharp post earnings swings are landing on top of a weak stretch for the stock, with a 20.54% 1 month share price return decline and a 25.08% year to date share price return pulling DoorDash to US$164.66. This comes even though the...

CEO Ryan Cohen and other GameStop executives have recently reported multiple insider share purchases. At the same time, several institutional investors have reduced their holdings in NYSE:GME. Management has not provided new details on previously discussed merger or combination plans, despite continued market interest. GameStop, trading on the NYSE under ticker GME, most recently closed at $23.64, with the stock up 14.6% year to date and 25.2% over the past 3 years. Over 1 year, the share...

Market context and recent share performance With no single headline event driving attention today, Upwork (UPWK) is drawing interest as investors reassess its recent share performance and current business profile in online freelance and remote work marketplaces. See our latest analysis for Upwork. Upwork’s share price has pulled back to US$12.51, with a 1 month share price return of 43.42% decline and a year to date share price return of 36.95% decline. The 3 year total shareholder return of...

If you are wondering whether Allegro MicroSystems is fairly priced or not, this article explains what the current share price might be implying about its value. The stock recently closed at US$38.48, with returns of 16.6% over the last 30 days, 43.0% year to date and 53.9% over the past year. Over the last 7 days it declined 9.2%, and the 3 year return sits at a 10.4% decline compared to 41.6% over 5 years. Recent coverage has focused on Allegro MicroSystems as a semiconductor company that...

Earlier in February 2026, Blue Bird reported quarterly sales and profits that exceeded expectations, highlighted growing order backlog and the delivery of 121 electric school buses. Analysts pointed to Blue Bird’s improving margin profile and its scarcity value in the specialty vehicle space following recent industry M&A as key positives. Now we’ll examine how these stronger-than-expected results, particularly the momentum in electric bus deliveries, may influence Blue Bird’s investment...

Why Ulta Beauty Stock Is On Investors’ Radar Ulta Beauty (ULTA) shares have drawn attention after recent performance data showed mixed short term moves alongside a stronger past year, putting the retailer’s valuation and growth profile back in focus for investors. See our latest analysis for Ulta Beauty. At around US$669.87 per share, Ulta Beauty has given back a little in the very short term, with recent 1 day, 7 day and 30 day share price returns all slightly negative. However, the 90 day...

Jazz Pharmaceuticals marked World Cholangiocarcinoma Day by supporting awareness efforts for this rare bile duct cancer. The company highlighted patient stories and advocacy partnerships as part of its rare disease engagement. This outreach focuses on education around cholangiocarcinoma, a condition that often receives limited public attention. For investors watching Jazz Pharmaceuticals, ticker NasdaqGS:JAZZ, this awareness push sits alongside a current share price of $173.25 and a 1-year...

Eaton (NYSE:ETN) is seeing strong long term demand from data centers, electrification projects, and grid investments. At the same time, the company’s CEO has recently sold shares, drawing attention to insider activity during a period of sector tailwinds. These developments are prompting investors to reassess how management actions line up with Eaton’s exposure to key electrical and power infrastructure themes. Eaton’s current share price of $362.05 is set against a backdrop of multi year...

Berkshire Hathaway (NYSE:BRK.B) appoints Greg Abel as CEO, following Warren Buffett’s departure. The leadership change coincides with a major wildfire settlement involving Berkshire’s PacifiCorp utility subsidiary. The settlement is intended to resolve wildfire damage claims and address related legal exposure. Berkshire Hathaway, the conglomerate spanning insurance, rail, utilities, energy and a wide range of operating businesses, is entering a new chapter with Greg Abel as CEO of...

If you are wondering whether Williams Companies is still reasonably priced after a strong run, you are not alone. This article will focus on what the current share price might imply about value. The stock last closed at US$72.98, with returns of 1.0% over 7 days, 12.3% over 30 days, 19.9% year to date and 31.7% over 1 year. The 3 year and 5 year returns are very large on a percentage basis. Recent news coverage has focused on Williams Companies as a key US energy infrastructure player, with...

Eli Lilly has already gained FDA approval to expand the label for its obesity drug Zepbound (tirzepatide) to include a four-dose, single-patient-use KwikPen that delivers a full month of treatment in one device, available via LillyDirect starting at US$299 per month for the 2.5 mg dose for self-pay patients. This new delivery option arrives just as a key rival, Novo Nordisk’s CagriSema, underperformed tirzepatide in a late-stage head-to-head obesity trial, sharpening Zepbound’s competitive...

Dominion Energy (D) has laid out its FY 2025 scorecard with third quarter revenue of US$4.5b and basic EPS of US$1.17, capped by trailing twelve month revenue of US$16.5b and EPS of US$3.47 that sit against a 60.5% year over year earnings jump and a 5.7% five year average earnings growth rate. The company has seen quarterly revenue move from US$3.4b in Q4 2024 to US$4.1b in Q1 2025, US$3.8b in Q2 2025 and US$4.5b in Q3 2025. Basic EPS shifted from a Q4 2024 loss of US$0.13 per share to...

Alarm.com Holdings (ALRM) just cleared a key hurdle for investors by reporting fourth quarter and full year 2025 results that topped expectations, and pairing that with higher 2026 SaaS and license revenue guidance. See our latest analysis for Alarm.com Holdings. Despite the upbeat earnings, 2026 guidance and ongoing acquisition plans, Alarm.com Holdings’ recent momentum has been weak, with a 30 day share price return of 9.59% and a 1 year total shareholder return of 26.67%, pointing to...

BWX Technologies reported past fourth-quarter 2025 results with sales of US$885.84 million and net income of US$92.99 million, alongside a US$0.27 quarterly dividend declared on February 18, 2026, payable March 27, 2026. Full-year 2025 sales of US$3.20 billion and net income of US$328.95 million, together with 2026 revenue guidance of about US$3.75 billion, underline how current operations and management expectations frame BWX Technologies’ longer-term earnings narrative. We’ll now examine...

Kinetik Holdings (NYSE:KNTK) is reported to be exploring a potential sale process. Western Midstream Partners has shown interest in a possible acquisition of Kinetik Holdings. The situation points to possible changes in ownership structure and future direction for the company. Kinetik Holdings, listed on the NYSE under ticker KNTK, operates in the midstream energy space, connecting upstream production with downstream demand through gathering, processing, and related services. Attention on...

Watsco (NYSE:WSO) announced that its Board of Directors approved a 10% increase in its annual dividend. The decision represents a material change in the company’s capital return to shareholders. Watsco, a large distributor of air conditioning, heating and refrigeration equipment, sits at the crossroads of residential and commercial demand for climate systems. For income focused investors, a 10% increase in the annual dividend is a meaningful signal about how the Board views the company’s...

Recent analyst upgrades have pushed CBRE Group (CBRE) back into focus, with firms citing the company’s position in commercial real estate and its guidance for meaningful growth even as AI related fee worries linger. See our latest analysis for CBRE Group. CBRE’s shares have pulled back recently, with a 30 day share price return of 14.8% and a year to date share price return of 10%. At the same time, the 1 year total shareholder return of 4.6% and 5 year total shareholder return of 85.9%...

Recent performance context for Dianthus Therapeutics Dianthus Therapeutics (DNTH) has drawn attention after a series of double digit returns over the past year, including a 6.3% move today and a 14.4% total return over the past 3 months. See our latest analysis for Dianthus Therapeutics. With the share price now at $52.68, Dianthus Therapeutics shows strong recent momentum, with a 7 day share price return of 11.14% and a 1 year total shareholder return of 143.89%, which may indicate shifting...

What Recent Performance Says About Napco Security Technologies Without a fresh headline event to react to, Napco Security Technologies (NSSC) is still drawing interest as investors look at how its recent share performance lines up with its current fundamentals. See our latest analysis for Napco Security Technologies. The recent share price return tells a story of building momentum, with Napco Security Technologies posting a 19.05% 1 month share price return and a 1 year total shareholder...

Dole's Colada Royale Pineapple has been named a 2026 Best New Product Awards Winner by BrandSpark International and Newsweek. The recognition highlights Dole's focus on product development within the fresh produce category. The award spotlights Colada Royale Pineapple as a differentiated offering in Dole's portfolio. Dole (NYSE:DOLE) operates across the fresh fruit and vegetable value chain, so a branded product win in a consumer awards program speaks directly to how its R&D and marketing...

Crinetics Pharmaceuticals (NasdaqGS:CRNX) reported positive clinical trial results for its congenital adrenal hyperplasia treatment. The company also announced positive initial sales for its oral therapy for acromegaly, alongside progress on related regulatory milestones. These updates highlight recent clinical and commercial developments in Crinetics' rare endocrine disease portfolio. Crinetics Pharmaceuticals focuses on therapies for rare endocrine conditions, an area where treatment...

Tariff shock and wholesale pressures hit Steven Madden shares The Trump administration's new global tariffs have put fresh attention on Steven Madden (SHOO), as its import heavy supply chain, soft wholesale and private label trends, and recent analyst downgrades all contribute to renewed share price pressure. See our latest analysis for Steven Madden. At a share price of $37.27, Steven Madden has seen a 1 day share price return decline of 6.57% and a 30 day share price return decline of...

What the latest earnings and buyback update means for Apollo Commercial Real Estate Finance (ARI) Apollo Commercial Real Estate Finance (ARI) just released fourth quarter and full year 2025 results, reporting quarterly income of US$29.2 million and a full year return to profitability, alongside the completion of a multi year share repurchase program. See our latest analysis for Apollo Commercial Real Estate Finance. The latest earnings rebound and completion of a multi year buyback sit...

The U.S. decision to impose a 15% global tariff for up to 150 days has put Starbucks (SBUX) in sharper focus, as investors reassess a business that is heavily tied to international sourcing and overseas operations. See our latest analysis for Starbucks. Despite the tariff headlines, Starbucks’ 90 day share price return of 10.32% and year to date share price return of 12.87% point to improving momentum. However, the 1 year total shareholder return decline of 13.95% shows that longer term...